FDA Hears Public Support for Psychedelic Drug Therapeutic Potential at 4-Hour Hearing
Source Summary
The FDA held a 4-hour public hearing Monday to gather feedback on the potential therapeutic use of psychedelic drugs. Most of the 80 speakers who testified expressed strong support for psychedelic medicine, citing its efficacy.
Why it matters
The hearing demonstrates FDA engagement with emerging evidence on psychedelic therapeutics and reflects growing public advocacy for regulatory pathways to develop these treatments.



